113  Total SME IPOs listed in 2025

5,113.46 Crs.  Total funds raised in 2025

78  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

113  Total SME IPOs listed in 2025

5,113.46 Crs.  Total funds raised in 2025

78  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

113  Total SME IPOs listed in 2025

5,113.46 Crs.  Total funds raised in 2025

78  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

113  Total SME IPOs listed in 2025

5113.46 Crs.  Total funds raised in 2,025.00

78  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

Medico Remedies Limited IPO Peer Comparison

Medico Remedies IPO is a SME IPO coming on BSE SME with an IPO size of 10.99 Cr. .
This IPO falls under the Pharmaceutical sector, which has seen 40 IPOs to date. Key sector metrics such as average PE ratio, IPO size, EBITDA margin, and PAT margin are compared below with the figures from the Medico Remedies IPO.

Medico Remedies
IPO Details


IPO Industry -
Pharmaceutical

IPOs So Far: 40

Issue Size (IPO)

₹ 10.99 Cr.

Total Fund Raised

₹ 879.72 Cr.

Average Issue Size

₹ 21.99 Cr.

PE Ratio (IPO)

52.00 x

Average PE Ratio

20.74 x

EBITDA Margin (IPO)

7.00 %

Average EBITDA Margin

14.77 %

PAT Margin (IPO)

1.37 %

Average PAT Margin

7.95 %

Medico Remedies
IPO Details

IPO Industry

Pharmaceutical

IPOs So Far 40


IPO Fund Raised

₹ 10.99 Cr.

Total Fund Raised

₹ 879.72 Cr.

Average Fund Raised

₹ 21.99 Cr.

IPO PE Ratio

52.00 x

IPO EBITDA

7.00 %

IPO PAT

1.37 %

Average PE Ratio

20.74 x

Average EBIDTA

14.77 %

Average PAT

7.95 %

Peer Comparison of Medico Remedies IPO in This Sector

You can do performance analysis for Medico Remedies IPO with Listed IPOs in the Pharmaceutical sector and review their IPO performance based on Merchant banker, Listing price, IPO Valuation and other metrics.

Select Listed IPO for Comparison:
Basis
Medico Remedies IPO
vs
vs
vs

IPO Date
8th February 2018


IPO Size
₹ 10.99 Cr.

PE Multiple
52.00 X

Listing Price
₹ 97.15 (-2.85%)

IPO Performance Report of Pharmaceutical Sector

This IPO report captures the post-listing performance of IPOs in the Pharmaceutical sector, featuring key metrics like offer price, listing gain, and CMP to help investors assess return potential and sector sentiment.

NAME OFFER PRICE LISTING PRICE LISTING GAIN CMP CMP %
Asston Pharmaceuticals IPO
Financial Report >>
₹ 123.00 ₹ 119.00 -3.25% ₹ 124 [●]
Astonea Labs IPO
Financial Report >>
₹ 135.00 ₹ 137.45 1.81% ₹ 179 32%
Accretion Pharmaceuticals IPO
Financial Report >>
₹ 101.00 ₹ 79.00 -21.78% ₹ 66 -35%
Hamps Bio IPO
Financial Report >>
₹ 51.00 ₹ 101.74 99.49% ₹ 38 -25%
Onyx Biotec IPO
Financial Report >>
₹ 61.00 ₹ 56.75 -6.97% ₹ 51 -16%
Medicamen Organics IPO
Financial Report >>
₹ 34.00 ₹ 144.70 325.59% ₹ 40 19%
Quest Laboratories IPO
Financial Report >>
₹ 97.00 ₹ 147.35 51.91% ₹ 92 -5%
Zenith Drugs IPO
Financial Report >>
₹ 79.00 ₹ 105.15 33.10% ₹ 74 -7%
Sunrest Lifescience IPO
Financial Report >>
₹ 84.00 ₹ 79.80 -5.00% ₹ 53 -37%
Mono Pharmacare IPO
Financial Report >>
₹ 28.00 ₹ 30.45 8.75% ₹ 24 -13%
Shelter Pharma IPO
Financial Report >>
₹ 42.00 ₹ 41.96 -0.10% ₹ 43 2%
Vilin Bio IPO
Financial Report >>
₹ 30.00 ₹ 30.00 [●] ₹ 26 -14%
Remus Pharmaceuticals IPO
Financial Report >>
₹ 1,229.00 ₹ 1,711.00 39.22% ₹ 913 -26%
Infinium Pharmachem IPO
Financial Report >>
₹ 135.00 ₹ 141.50 4.81% ₹ 288 113%
Sotac Pharmaceuticals IPO
Financial Report >>
₹ 111.00 ₹ 115.00 3.60% ₹ 130 17%
Sudarshan Pharma IPO
Financial Report >>
₹ 73.00 ₹ 73.00 [●] ₹ 29 -61%
Patron Exim IPO
Financial Report >>
₹ 27.00 ₹ 28.40 5.19% ₹ 6 -77%
Trident Lifeline IPO
Financial Report >>
₹ 101.00 ₹ 108.15 7.08% ₹ 270 167%
Dipna Pharmachem IPO
Financial Report >>
₹ 38.00 ₹ 33.40 -12.11% ₹ 25 -35%
JFL Life IPO
Financial Report >>
₹ 61.00 ₹ 66.50 9.02% ₹ 15 -75%
Jeena Sikho IPO
Financial Report >>
₹ 150.00 ₹ 173.50 15.67% ₹ 537 258%
Achyut Healthcare IPO
Financial Report >>
₹ 20.00 ₹ 21.15 5.75% ₹ 4 -79%
Evoq Remedies IPO
Financial Report >>
₹ 27.00 ₹ 23.75 -12.04% ₹ 4 -83%
Fabino Life IPO
Financial Report >>
₹ 36.00 ₹ 40.35 12.08% ₹ 26 -27%
Chandra Bhagat IPO
Financial Report >>
₹ 51.00 ₹ 51.76 1.49% ₹ 58 14%
Earum Pharmaceuticals IPO
Financial Report >>
₹ 36.00 ₹ 36.05 0.14% ₹ 1 -97%
Cian Healthcare IPO
Financial Report >>
₹ 61.00 ₹ 61.50 0.82% ₹ 4 -94%
Par Drugs IPO
Financial Report >>
₹ 51.00 ₹ 51.45 0.88% ₹ 101 98%
Deccan Health IPO
Financial Report >>
₹ 100.00 ₹ 113.40 13.40% ₹ 21 -79%
Medico Remedies IPO
Financial Report >>
₹ 100.00 ₹ 97.15 -2.85% ₹ 40 98%
Beta Drugs IPO
Financial Report >>
₹ 85.00 ₹ 101.95 19.94% ₹ 1,720 1924%
Vanta Bioscience IPO
Financial Report >>
₹ 50.00 ₹ 50.20 0.40% ₹ 29 -41%
Dhruv Wellness IPO
Financial Report >>
₹ 20.00 ₹ 19.50 -2.50% ₹ 5 -73%
ANG Lifesciences IPO
Financial Report >>
₹ 80.00 ₹ 96.00 20.00% ₹ 31 -61%
Vaishali Pharma IPO
Financial Report >>
₹ 72.00 ₹ 70.35 -2.29% ₹ 13 -10%
Zota Health IPO
Financial Report >>
₹ 125.00 ₹ 125.60 0.48% ₹ 1,209 867%
Sakar Healthcare IPO
Financial Report >>
₹ 50.00 ₹ 52.15 4.30% ₹ 355 610%
Kwality Pharmaceuticals IPO
Financial Report >>
₹ 45.00 ₹ 44.50 -1.11% ₹ 1,185 2533%
Bajaj Healthcare IPO
Financial Report >>
₹ 170.00 ₹ 171.50 0.88% ₹ 525 2988%
Ganga Pharmaceuticals IPO
Financial Report >>
₹ 15.00 ₹ 14.50 -3.33% ₹ 15 -1%

Sector wise SME IPO Performance Report Available >>

Medico Remedies IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.

FAQs of Medico Remedies IPO

Who are the peers of Medico Remedies IPO?

The peers of Medico Remedies , include other listed companies operating in the (Pharmaceutical) segment. These peer companies typically offer similar services Some of the notable peers as per the DRHP of this company are .
See the complete list of current IPO

What is Peer Comparison in IPO Analysis?

Peer Comparison is the method of evaluating an entity by comparing its performance, size of business form other entities operating in same industry or sector. It involves financial analysis bycomparing key financial metrics like Profitability, Net worth, Market Capitalization and Leverage. Peer comparison is beneficial for investors to make informed investment decisions and to identify any potential risks. IPO Performance tracker

Why Peer Comparison is important for IPO Review?

Peer comparison helps to identify companies in the same sector with a similar business. It helps to compare the financial performance and valuation against its listed peers. An investor or an analyst can decide whether the IPO price is justified when compared to its peers. An investor can make informed decision whether to apply to IPO or not on basis of peer comparison. Know the process of DRHP and Peer companies Information required to be disclosed in DRHP.

As of now 40 SME IPOs are listed in this sector indicating strong growth in this sector. Choosing the best IPO depends on factors like, financial performance, valuation, market trends and future growth plans. IPO Review and performance.

What is a good PE ratio for an Pharmaceutical company?

A good PE Ratio for Pharmaceutical sector depends on various factors like, performance of the company, market conditions, company valuation and IPO Size. PE Ratio varies from sector to sector and company to company. Know the average PE Multiple in each sector.

How many companies are listed in the Pharmaceutical sector?

Currently 40 companies are listed under Pharmaceutical sector. Based on the latest data from the Stock Exchanges. Choose the Best Merchant Banker from the Merchant Banker List

Is Medico Remedies IPO good in comparison with its competitors?

Performance of companies depends on various factors like, profits, future plans, Market share, PE Ratio etc. By assessing these factors investor can make better investment decisions.Medico Remedies Peer comparison provides IPO analysis of companies listed in this sector, on the basis of different Key performance indicators (KPI)like, Listing Gain of peers, current market price, PE Ratio and IPO Size.

Which are the Upcoming IPO in the Pharmaceutical sector?

Upcoming IPO refers to companies which have filed their DRHP with the Stock exchange and are awaiting approval from NSE Emerge or BSE SME. 14 companies have filed their DRHP for SME IPO under Pharmaceutical sector. .New IPO 2025-2026 and Upcoming IPO

How to calculate the PE multiple based on your sector?

PE Multiple is a metrics that is widely used for IPO Valuation. Merchant bankers in coordination with the company decides the PE Multiple.The PE Multiple depends on various factors and it should be analyzed in coordination with other financial metrics. Know the PE ratio of your company with PE Calculator provided by IPOplatform

Explore Other DRHPs

Asston Pharmaceuticals Limited

  Pharmaceutical

  Mumbai


Astonea Labs Limited

  Pharmaceutical

  Chandigarh


Accretion Pharmaceuticals Limited

  Pharmaceutical

  Ahmedabad


Hamps Bio Limited

  Pharmaceutical

  Bharuch


Onyx Biotec Limited

  Pharmaceutical

  Solan


Read more details of this IPO

Peer Companies Of This Sector

FAQs

Medico Remedies operates in Pharmaceutical and Manufacturing And Selling Of Pharmaceutical Formulation Products In India.. The Issue is listed on BSE SME in Feb, 2018. Medico Remedies IPO size was 10.99 with Issue price of 100.00 .

Medico Remedies IPO subscription was 1.84 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Medico Remedies IPO listed at a listing price of 97.15 against the offer price of 100.00.

The current market price of Medico Remedies is 39.60.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency